Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H34O5 |
Molecular Weight | 390.5131 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](C(=O)COC(C)=O)[C@@]1(C)CC(=O)[C@@]3([H])[C@@]2([H])CC[C@@]4([H])C[C@H](O)CC[C@]34C
InChI
InChIKey=QRJOQYLXZPQQMX-FWROMSNXSA-N
InChI=1S/C23H34O5/c1-13(24)28-12-20(27)18-7-6-17-16-5-4-14-10-15(25)8-9-22(14,2)21(16)19(26)11-23(17,18)3/h14-18,21,25H,4-12H2,1-3H3/t14-,15+,16-,17-,18+,21+,22-,23-/m0/s1
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/11573627
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11573627
Alfadolone or alphadolone is an oral neurosteroid, which can be useful as an analgesic.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11573627 |
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Controlled sedation with alphaxalone-alphadolone. | 1974 Jun 22 |
|
Antinociceptive properties of neurosteroids IV: pilot study demonstrating the analgesic effects of alphadolone administered orally to humans. | 2001 Apr |
|
Antinociceptive properties of neurosteroids III: experiments with alphadolone given intravenously, intraperitoneally, and intragastrically. | 2001 May |
|
Prevention and reversal of morphine tolerance by the analgesic neuroactive steroid alphadolone. | 2009 Jul-Aug |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/11573627
alphadolone (25-500 mg, n = 9) or placebo (lactose, n = 5) given orally 1 h after operation
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
245-942-5
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | |||
|
C98249
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | |||
|
C033418
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | |||
|
m1498
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | Merck Index | ||
|
23930-37-2
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | |||
|
SUB00336MIG
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | |||
|
5045
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | |||
|
Alfadolone acetate
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | |||
|
100000078856
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | |||
|
DTXSID7045443
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | |||
|
00TN4GS00S
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY | |||
|
24733
Created by
admin on Fri Dec 15 16:58:56 GMT 2023 , Edited by admin on Fri Dec 15 16:58:56 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD